HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)

intermediate in the synthesis of imidazolineoxyl N-oxides; partial structure given in first source
Also Known As:
NOR 1; 1,3-DTCTI; 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; cPTIO; carboxy-PTIO
Networked: 59 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Crestani, Carlos C: 3 articles (11/2020 - 01/2019)
2. Muscat, George E O: 3 articles (06/2016 - 06/2005)
3. Tokuda, Harukuni: 3 articles (09/2009 - 02/2005)
4. Almeida, Jeferson: 2 articles (01/2020 - 01/2019)
5. Benini, Ricardo: 2 articles (01/2020 - 01/2019)
6. Oliveira, Leandro A: 2 articles (01/2020 - 01/2019)
7. Goode, Joel M: 2 articles (06/2016 - 03/2012)
8. Pearen, Michael A: 2 articles (06/2016 - 03/2012)
9. Chen, Hung-Yi: 2 articles (06/2009 - 09/2006)
10. Chen, Tsung-Ying: 2 articles (06/2009 - 09/2006)

Related Diseases

1. Shock
2. Hypotension (Low Blood Pressure)
3. Urinary Bladder Neoplasms (Bladder Cancer)
4. Ischemia
5. Endotoxemia

Related Drugs and Biologics

1. Nitric Oxide (Nitrogen Monoxide)
2. Nitric Oxide Synthase (NO Synthase)
3. Adenosine Triphosphate (ATP)
4. Lipopolysaccharides
5. Lactic Acid (Lactate)
6. Oxides
7. Alanine (L-Alanine)
8. 7-nitroindazole
9. N(G)-iminoethylornithine
10. 1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)

Related Therapies and Procedures

1. Lasers (Laser)
2. Intravenous Infusions
3. Controlled Hypotension
4. Therapeutics
5. Treatment Delay